PRODUCTS SERVICES COMPANY CONTACT FAQ

Search Dictionary Mobile

Login

Mohan Bala Selected Research

infliximab (Remicade)

09/2007	Infliximab treatment improves productivity among patients with moderate-to-severe psoriasis.
07/2007	Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early rheumatoid arthritis.
04/2007	The effects of infliximab therapy on health-related quality of life in ulcerative colitis patients.
01/2007	The impact of infliximab treatment on quality of life in patients with inflammatory rheumatic diseases.
11/2006	Effect of infliximab therapy on employment, time lost from work, and productivity in patients with psoriatic arthritis.
08/2006	Infliximab improves productivity and reduces workday loss in patients with ankylosing spondylitis: results from a randomized, placebo-controlled trial.
03/2006	Infliximab treatment maintains employability in patients with early rheumatoid arthritis.
03/2006	Scheduled maintenance treatment with infliximab is superior to episodic treatment for the healing of mucosal ulceration associated with Crohn's disease.
03/2006	Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial.
04/2005	Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulizing Crohn's disease.
10/2004	Infliximab induction therapy for patients with severe plaque-type psoriasis: a randomized, double-blind, placebo-controlled trial.
07/2004	Incidence and importance of antibody responses to infliximab after maintenance or episodic treatment in Crohn's disease.
07/2002	Infliximab improves quality of life in patients with Crohn's disease.

Articles by Research Topic

Disease

4	Crohn Disease (Crohn's Disease) 03/2006 - 07/2002
3	Rheumatoid Arthritis 07/2007 - 03/2006
2	Psoriasis (Pustulosis Palmaris et Plantaris) 09/2007 - 10/2004
1	Inflammation 07/2007
1	Ulcerative Colitis 04/2007
1	Rheumatic Diseases (Rheumatism) 01/2007
1	Psoriatic Arthritis 11/2006
1	Ankylosing Spondylitis 08/2006

Drug/Important Bio-Agent (IBA)

13	infliximab (Remicade)FDA Link 09/2007 - 07/2002
2	Methotrexate (Mexate)FDA LinkGeneric 07/2007 - 03/2006
1	Biological Markers (Surrogate Marker)IBA 07/2007